
Sign up to save your podcasts
Or


When a new drug class enters the veterinary world, first comes the excitement…then comes the learning. In this episode of Clinician’s Brief Partner Podcast, Jocelyn Mott, DVM, DACVIM, answers your most frequently asked questions when it comes to using a novel drug class in the treatment of feline diabetes mellitus: the sodium-glucose cotransporter-2 inhibitor. Tune in as she explains when, how, and why to consider this option in newly diagnosed feline diabetics.
Sponsored by Elanco
Resource:
Contact us:
Where to find us:
The Team:
By Clinician's Brief4.5
9999 ratings
When a new drug class enters the veterinary world, first comes the excitement…then comes the learning. In this episode of Clinician’s Brief Partner Podcast, Jocelyn Mott, DVM, DACVIM, answers your most frequently asked questions when it comes to using a novel drug class in the treatment of feline diabetes mellitus: the sodium-glucose cotransporter-2 inhibitor. Tune in as she explains when, how, and why to consider this option in newly diagnosed feline diabetics.
Sponsored by Elanco
Resource:
Contact us:
Where to find us:
The Team:

22 Listeners

188 Listeners

45 Listeners

94 Listeners

54 Listeners

138 Listeners

18 Listeners

4,484 Listeners

176 Listeners

137 Listeners

47 Listeners

31 Listeners

33 Listeners

12 Listeners

379 Listeners